Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 02, 2026, titled "Emcure Pharma Reduces Poviztra® Starting Dose Price by 55% to Expand Patient Access".
Press Release Apr 02 2026
Earlier from Emcure Pharmaceuticals
- Press Release Mar 02 2026
- Press Release Dec 22 2025
- Press Release Nov 10 2025
- Press Release Jul 16 2025